Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer
Summary: Cancer cells overexpress a diversity of anti-apoptotic BCL-2 family proteins, such as BCL-2, MCL-1, and BFL-1/A1, to enforce cellular immortality. Thus, intensive drug development efforts have focused on targeting this class of oncogenic proteins to overcome treatment resistance. Whereas a...
Main Authors: | Rachel M. Guerra, Gregory H. Bird, Edward P. Harvey, Neekesh V. Dharia, Kyle J. Korshavn, Michelle S. Prew, Kimberly Stegmaier, Loren D. Walensky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718314086 |
Similar Items
-
The C-terminal region of <it>Bfl-1 </it>sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing <it>NF-κB </it>activity and down-regulating Bfl-1
by: Kim Min-Kyoung, et al.
Published: (2011-08-01) -
Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival.
by: Maria Ekoff, et al.
Published: (2012-01-01) -
Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening
by: Dutta, Sanjib, et al.
Published: (2015) -
Design of Druglike Small Molecules for Possible Inhibition of Antiapoptotic BCL-2, BCL-W, and BFL-1 Proteins
by: D.S. Dalafave
Published: (2010-01-01) -
Design of Druglike Small Molecules for Possible Inhibition of Antiapoptotic BCL-2, BCL-W, and BFL-1 Proteins
by: D.S. Dalafave
Published: (2010-09-01)